Revive Therapeutics Logo White

Revive Therapeutics

CSE: RVV | OTC: RVVTF 

Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly.

Revive Therapeutics
$0.135
0.00%
$0.0000

Latest News

Revive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

January 20, 2023

Revive Therapeutics legt aktualisiertes Informationspaket zur Unterstützung der bevorstehenden Sitzung des Typs C vor, die von der FDA für die geänderte Prüfplanvereinbarung der klinischen Phase-III-Studie für Bucillamin zur Behandlung von COVID-19 genehmigt wurde

January 15, 2023

Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

January 5, 2023

Revive Therapeutics Announces Submission of Type C Meeting Request to FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

December 24, 2022

Revive Therapeutics Ltd. Expands Life Offering to Quebec

December 15, 2022

Revive Therapeutics Ltd. Announces Offering of Up to $5 Million

December 1, 2022

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.